BD Lunch Symposium at ANESTHESIOLOGY® 2026

ANESTHESIOLOGY^® 2026

Managing Under Pressure: Detecting Hemodynamic Instability Before It Demands Intervention

Detecting hemodynamic instability before it demands intervention requires more than intermittent monitoring. Join leading experts as they explore how continuous noninvasive blood pressure monitoring and advanced hemodynamic parameters can enhance situational awareness and guide timely clinical decisions in all surgeries including OB/GYN, NORA and management of the physiologically difficult airway.

Sunday, October 18 | 12:00 pm - 1:00 pm

San Diego Convention Center | Room 5AB

Faculty Speakers

Barbara Orlando

MD, PhD, FASA

Chief of Obstetric Anesthesiology

Bernd Saugel

Univ. Medical Center, Hamburg, Germany

Anil Patel

MBBS, PhD, FRCA

Chairman, Dept. of Anesthesia

Moderators

Monty Mythen

MBBS, MD, FRCA, FFICM
SVP Medical Affairs
BD Advanced Patient Monitoring

Desirée Chappell

CRNA, FAANA
Director, Medical Affairs

BD Advanced Patient Monitoring

Explore Technologies Supporting Early Identification of Hemodynamic Instability at #ANES2026

HemoSphere Alta™ Monitor

Explore the Power of Predictive Monitoring

Because care isn’t just about reacting, it’s about anticipating. HemoSphere Alta™ Monitor allows you to unlock innovative, smart and predictive algorithms that can help you detect hemodynamic instability before it occurs. With a range of compatible sensors, you can tailor which parameters are monitored for individualized patient care.

Acumen Hypotension Prediction Index™ (HPI™) Software
Acumen IQ™ Sensor
ForeSight IQ™ Sensor
Acumen IQ™ Plus Cuff
Swan-Ganz IQ™ Catheter

Learn more about advanced hemodynamic monitoring technologies →

Monty Mythen and Desirée Chappell are employees of BD (Becton, Dickinson and Company).
Other speakers are paid consultants of BD (Becton, Dickinson and Company).

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

This course does not provide CME credits. Participant spouses or guests may not attend, and no items or benefits will be provided to them. Speakers, instructors, moderators and/or panelists may receive compensation and reimbursement of reasonable travel expenses from BD for their services in compliance with applicable laws and the AdvaMed Code of Ethics. The value of any food or refreshments provided by BD at this meeting will be apportioned among all attendees. If you expressly decline to partake of any offered food or refreshments, or desire to personally pay for such food or refreshments, please let your BD representative know.

Distributed by BD, 17200 Laguna Canyon Road, Irvine, CA 92618

BD, the BD Logo, Acumen, Acumen IQ, ForeSight, ForeSight IQ, HemoSphere, HemoSphere Alta, HPI, Hypotension Prediction Index, Swan, Swan-Ganz and Swan-Ganz IQ are the property of Becton, Dickinson and Company or its affiliates. All other trademarks are the property of their respective owners.